Publication: Nicotine prevents and reverses paclitaxel-induced mechanical allodynia in a mouse model of CIPN
No Thumbnail Available
Date
2018-01-01
Authors
Bağdaş, Deniz
Authors
Kyte, S. Lauren
Toma, Wisam
Meade, Julie A.
Schurman, Lesley D.
Lichtman, Aron H.
Chen, Zhi-Jian
Del Fabbro, Egidio
Fang, Xianjun
Bigbee, John W.
Damaj, M. Imad
Journal Title
Journal ISSN
Volume Title
Publisher
American Society for Pharmacology and Experimental Therapy
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN), a consequence of peripheral nerve fiber dysfunction or degeneration, continues to be a dose-limiting and debilitating side effect during and/or after cancer chemotherapy. Paclitaxel, a taxane commonly used to treat breast, lung, and ovarian cancers, causes CIPN in 59-78% of cancer patients. Novel interventions are needed due to the current lack of effective CIPN treatments. Our studies were designed to investigate whether nicotine can prevent and/or reverse paclitaxel-induced peripheral neuropathy in a mouse model of CIPN, while ensuring that nicotine will not stimulate lung tumor cell proliferation or interfere with the antitumor properties of paclitaxel. Male C57BL/6J mice received paclitaxel every other day for a total of four injections (8 mg/kg, i.p.). Acute (0.3-0.9 mg/kg, i.p.) and chronic (24 mg/kg per day, s.c.) administration of nicotine respectively reversed and prevented paclitaxel-induced mechanical allodynia. Blockade of the antinociceptive effect of nicotine with mecamylamine and methyllycaconitine suggests that the reversal of paclitaxel-induced mechanical allodynia is primarily mediated by the alpha 7 nicotinic acetylcholine receptor subtype. Chronic nicotine treatment also prevented paclitaxel-induced intraepidermal nerve fiber loss. Notably, nicotine neither promoted proliferation of A549 and H460 non-small cell lung cancer cells nor interfered with paclitaxel-induced antitumor effects, including apoptosis. Most importantly, chronic nicotine administration did not enhance Lewis lung carcinoma tumor growth in C57BL/6J mice. These data suggest that the nicotinic acetylcholine receptor-mediated pathways may be promising drug targets for the prevention and treatment of CIPN.
Description
Keywords
Pharmacology & pharmacy, Induced peripheral neuropathy, Lung-cancer cells, Breast-cancer, Acetylcholine-receptors, Accelerated senescence, Postoperative pain, Tumor-cells, In-vıtro, Growth, Mice
Citation
Kyte, S. L. vd. (2018). ''Nicotine prevents and reverses paclitaxel-induced mechanical allodynia in a mouse model of CIPN''. Journal of Pharmacology and Experimental Therapeutics, 364(1), 110-119.